FEB 19, 2020 7:10 AM PST

Testing the Immune Response to Ovarian Cancer Treatment

WRITTEN BY: Kara Marker

There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diagnostics lead to catching cases of ovarian sooner, improving treatment options and prognoses.

The new diagnostic test was assessed in a recent clinical trial conducted in two cohorts of women with advanced ovarian cancer from two hospitals in Melbourne, Australia.

The new diagnostic test quantifies the body’s immune response to potential ovarian tumors by testing the blood for cancer markers as well as a specific immune biomarker for inflammation – interleukin (IL)-6. The presence of these biomarkers can help differentiate harmless ovarian cysts from malignant epithelial ovarian cancer. The most common form of ovarian cancer begins in the epithelial cells (GHR).

The new test is, according to senior author and chief investigator Magdalena Plebanski, “as accurate as the combined results of a standard blood test and ultrasound.” Utilizing the new diagnostic test eliminates need for MRI scans or ultrasounds. Improving the way women are diagnosed with ovarian cancer could reduce the number of needless operations, as women with harmless cysts would know they don’t need surgical removal.

 “This is especially important for women in remote or disadvantaged communities, where under-resourced hospitals may not have access to complex and expensive equipment like ultrasound machines or MRI scanners,” Plebanski added.

While the current study only included women with advanced ovarian cancer, future clinical trials testing the accuracy of this new test could include women with earlier stages of ovarian cancer.

About Ovarian Cancer

Ovarian cancer is one of the most common gynecologic cancers. Every year, 300,000 new cases of ovarian cancer are diagnosed across the world. 60 percent of women die within five years of diagnosis.

Sources: RMIT University, Scientific Reports

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 18, 2021
Neuroscience
Histamine Regulates Serotonin Levels in Depression
AUG 18, 2021
Histamine Regulates Serotonin Levels in Depression
Heightened histamine levels from inflammation inhibit the effects of the mood-regulating neurotransmitter serotonin in t ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 01, 2021
Coronavirus
It Seems Not All COVID-19 Patients Develop Antibodies
SEP 01, 2021
It Seems Not All COVID-19 Patients Develop Antibodies
It's been generally assumed that people who get infected with SARS-COV-2 will develop antibodies to the virus, which cau ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
Loading Comments...